Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS8179 for severe cerebral edema after large ischemic stroke
CTR20223435Phase 2Completed
- Sponsor
- Beijing Shengdi Pharmaceutical
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS8179 in cerebral edema, ischemic stroke, sponsored by Beijing Shengdi Pharmaceutical. Started Jan 2023; status: completed.
02
Drugs
HRS8179
03
Conditions
cerebral edemaischemic stroke
Beyond the preview
Go deeper on CTR20223435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223435.